HIGHLIGHTS
- who: Carina C. dos Santos et al. from the Universidade Su00e3o Paulo, Su00e3o Paulo, Brazil have published the Article: Recombinant BCG-LTAK63 Vaccine Candidate for Tuberculosis Induces an Inflammatory Profile in Human Macrophages, in the Journal: Vaccines 2022, 831 of /2022/
- what: The BCG vaccine does not sufficiently prevent pulmonary tuberculosis in adults ; thus, new prevention or treatment strategies are required to control the infection spread, and these are part of the main goals of the World Health Organization`s End TB Strategy . The authors used three different mycobacterial strains: Mtb H37Rv, a virulent strain . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.